Roy H. Larsen - Concepedia

Author

Roy H. Larsen

University of Oslo ORCID

Also Known As

Baker, J Miller, R H Larsen, R Larsen, R. H. Larsen, R. Larsen, R.H. Larsen, RH Larsen, ROY HARTVIG LARSEN, ROY LARSEN

111

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

University of Oslo Oslo University Hospital Norwegian Cancer Society Oncoinvent (Norway)Bayer (Norway)

About

Roy H. Larsen is an author at University of Oslo specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	26	1.2K
2	Engineering	8	8	532
3	Natural Sciences	5	5	203
4	Biochemistry	4	4	149
5	Health Sciences	3	3	109

Roy H. Larsen

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
First Clinical Experience with α-Emitting Radium-223 in the Treatment of Skeletal Metastases Sten Nilsson, Roy H. Larsen, Sophie D. Fosså, Clinical Cancer Research	2005	430
Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model. Gjermund Henriksen, Knut Breistøl, Øyvind S. Bruland, PubMed EngineeringPathologySignificant Antitumor EffectTumor BiologyNude Rats	2002	281
Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice. Gjermund Henriksen, Darrell R. Fisher, John C. Roeske, PubMed	2003	251
Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (α,2n)211At reaction Roy H. Larsen, Bruce W. Wieland, Michael R. Zalutsky Applied Radiation and Isotopes Natural SciencesInternal Cyclotron TargetChemistryNuclear Physics	1996	102
Sterically stabilized liposomes as a carrier for α-emitting radium and actinium radionuclides Gjermund Henriksen, Bent W. Schoultz, Terje E. Michaelsen, Nuclear Medicine and Biology α-Emitting RadiumLipid PreparationActinium RadionuclidesChemistryLipid Chemistry	2004	98
Evaluation of potential chelating agents for radium Gjermund Henriksen, P. Hoff, Roy H. Larsen Applied Radiation and Isotopes MedicineEnvironmental Analytical ChemistryRadioanalytical ChemistryAnalytical ChemistryPotential Chelating Agents	2002	82
Targeted cancer therapy with a novel low-dose rate α-emitting radioimmunoconjugate Jostein Dahle, Jørgen Borrebæk, Thora J. Jónasdóttir, Blood	2007	80
Blocking [211At]Astatide Accumulation in Normal Tissues: Preliminary Evaluation of Seven Potential Compounds Roy H. Larsen, Susan Slade, Michael R. Zalutsky Nuclear Medicine and Biology Normal TissuesBiochemistryPreliminary EvaluationMedicinePhysiology	1998	74
Radiotoxicity of the alpha-emitting bone-seeker 223Ra injected intravenously into mice: histology, clinical chemistry and hematology. Roy H. Larsen, Henrik Saxtorph, Mikala Skydsgaard, PubMed	2006	66
The Cytotoxicity and Microdosimetry of Astatine-211-Labeled Chimeric Monoclonal Antibodies in Human Glioma and Melanoma Cells In Vitro Roy H. Larsen, Gamal Akabani, Philip Welsh, Radiation Research ImmunologyImmunoeditingHigh-grade GliomasImmunotherapyGlioma	1998	61

Page 1